Accelmed Partners led a $20 million investment in Acclaro Medical to support the development of its innovative laser technologies and expand its global market presence.

Target Information

Acclaro Medical is an innovative medical technology company that specializes in developing advanced solutions aimed at enhancing patient care and transforming medical practices. Established in 2018, Acclaro Medical has developed its flagship product, the UltraClear® fiber laser, which has garnered recognition from leading aesthetic professionals for its groundbreaking approach to Total Skin Health. This device is the first of its kind to feature a 2910 nm cold ablative fiber laser, utilizing the proprietary 3DIntelliPulse™ technology to effectively treat multiple skin layers and rejuvenate the skin by reversing signs of aging.

The UltraClear laser provides precise and transformative results with minimal downtime, reduced patient discomfort, and rapid recovery times. In addition to UltraClear, the AuraLux laser incorporates Cool Pulse™ technology, which enhances its accessibility while upholding Acclaro's commitment to quality and efficacy in aesthetic treatments.

Industry Overview in the United States

The aesthetic medical technology sector in the United States has shown remarkable growth, driven by increasing consumer demand for non-invasive and minimally invasive treatments. This demand is attributed to a rising awareness of aesthetic health and an agin